A
Alcista
Alcista · 25%MRM
$1.40
Precio del escenario
$0.284
-0.004 (-1.46%)Al cierre
Loading chart…
- Máximo
- 0.300
- Apertura
- 0.300
- Precio medio ponderado por volumen
- 0.29
- Volumen
- 13.98K
- Capitalización
- 18.55M
- Mínimo
- 0.280
- Importe
- 4.03K
- EV/EBITDA, TTM
- 0.00
Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices.
Análisis de IA of Medirom Healthcare Technologies Inc (MRM)
VenderMedirom Healthcare Technologies Inc (MRM) is not a good buy right now due to its extremely low RSI of 12.99, indicating it is oversold, and a staggering year-to-date change of -85.49%. The company's gross margin has improved to 99.65% in the last quarter, but the overall financial health is concerning with a debt-to-equity ratio of 174.83% and a current ratio of only 1.75, suggesting liquidity issues. The main risk is the significant decline in stock price, which has dropped 48.57% over the last 20 days, indicating a lack of investor confidence and potential further declines.
Métricas de valoración
El PER previsto actual de Medirom Healthcare Technologies Inc (MRM) es 0.00, frente a su media de 5 años de 0.00.
Escenarios de precio de Alphio AI para MRM
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
8.506-18Yahoo FinanceMicromem Closes C$235,000 Private Placement
7.505-28NewsfilterQ1 2026 Business Performance Overview
- 7.502-27Newsfilter
MEDIROM Partners with Tools for Humanity Under New Agreement
8.501-14Yahoo FinanceMicromem Technologies Closes C$327,778 Private Placement
9.001-09BusinesswireMRM Health Receives FDA Clearance to Initiate MH002 Clinical Trial
Preguntas frecuentes sobre MRM, respondidas por Alphio AI
Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices. It operates in the Consumer Non-Cyclicals sector.
Medirom Healthcare Technologies Inc (MRM) is not a good buy right now due to its extremely low RSI of 12.99, indicating it is oversold, and a staggering year-to-date change of -85.49%. The company's gross margin has improved to 99.65% in the last quarter, but the overall financial health is concerning with a debt-to-equity ratio of 174.83% and a current ratio of only 1.75, suggesting liquidity issues. The main risk is the significant decline in stock price, which has dropped 48.57% over the last 20 days, indicating a lack of investor confidence and potential further declines.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarArtículos relacionados
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.